JAMA Cardiology Author Interviews-logo

JAMA Cardiology Author Interviews

Medical

Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.

Location:

United States

Description:

Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.

Language:

English


Episodes
Pídele al anfitrión que permita compartir el control de reproducción

Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement

5/15/2024
Interview with Jonathan Afilalo, MD, MSc, author of Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement. Hosted by Robert O. Bonow, MD. Related Content: Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement

Duración:00:22:57

Pídele al anfitrión que permita compartir el control de reproducción

Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

4/17/2024
Interview with Sanjiv J. Shah, MD, author of Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

Duración:00:18:30

Pídele al anfitrión que permita compartir el control de reproducción

A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I

3/27/2024
Interview with Gaurav A. Upadhyay, MD, and Jeremy S. Treger, MD, PhD, authors of A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. Hosted by Kristen K. Patton, MD. Related Content: A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I

Duración:00:17:19

Pídele al anfitrión que permita compartir el control de reproducción

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV

2/21/2024
Interview with Michael T. Lu, MD, MPH, author of Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial, and Matthew J. Feinstein, MD, MSc, author of Statins, Inflammation, and Tissue Context in REPRIEVE. Hosted by Robert Bonow, MD. Related Content: Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIVStatins, Inflammation, and Tissue Context in REPRIEVE

Duración:00:21:18

Pídele al anfitrión que permita compartir el control de reproducción

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

11/15/2023
Interview with Sanjiv J. Shah, MD, author of Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

Duración:00:21:48

Pídele al anfitrión que permita compartir el control de reproducción

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

10/25/2023
Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular DysfunctionAssessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive

Duración:00:20:58

Pídele al anfitrión que permita compartir el control de reproducción

Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

9/27/2023
Interview with Muthiah Vaduganathan, MD, MPH, and John W. Ostrominski, MD, authors of Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. Hosted by Sadiya Sana Khan, MD, MSc. Related Content: Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

Duración:00:18:24

Pídele al anfitrión que permita compartir el control de reproducción

Assisted Reproductive Technologies and Maternal Cardiovascular Disease

8/9/2023
Interview with Maria C. Magnus, PhD, author of Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies, and Sadiya S. Khan, MD, MSc, author of Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter. Hosted by Roxana Mehran, MD Related Content: Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive TechnologiesAssisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter

Duración:00:12:01

Pídele al anfitrión que permita compartir el control de reproducción

Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping

7/19/2023
Interview with Marianna Fontana, MD, PhD, author of Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping, and Sarah A. M. Cuddy, MB, BCh, BAO, author of Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis. Hosted by James Udelson, MD. Related Content: Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 MappingImaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis

Duración:00:20:38

Pídele al anfitrión que permita compartir el control de reproducción

Percutaneous Microaxial Left Ventricular Assist Device for Patients With Cardiogenic Shock

6/21/2023
Interview with Robert W. Yeh, MD, MSc, author of Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock, and David J. Cohen, MD, MSc, and Manesh R. Patel, MD, authors of Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart. Hosted by Ajay J. Kirtane, MD, SM. Related Content: Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic ShockEvidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart

Duración:00:20:09

Pídele al anfitrión que permita compartir el control de reproducción

Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy

5/17/2023
Interview with Sharlene M. Day, MD, Rachel Lampert, MD, and Michael J. Ackerman, MD, PhD, authors of Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. Hosted by Robert Bonow, MD. Related Content: Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy

Duración:00:21:06

Pídele al anfitrión que permita compartir el control de reproducción

Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

4/26/2023
Interview with Ajay J. Kirtane, MD, SM, author of Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. Hosted by Clyde W. Yancy, MD, MSc. Related Content: Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO TrialsIs There a Role for Renal Denervation in the Treatment of Hypertension?

Duración:00:16:31

Pídele al anfitrión que permita compartir el control de reproducción

Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma

3/29/2023
Interview with Jenica N. Upshaw, MD, MS, author of Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma, and Ana Barac, MD, PhD, author of Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango. Hosted by Robert Bonow, MD. Related Content: Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell LymphomaAssessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango

Duración:00:20:47

Pídele al anfitrión que permita compartir el control de reproducción

Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care

2/15/2023
Interview with Søren Zöga Diederichsen, MD, PhD, author of Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care: Post Hoc Analysis of the LOOP Randomized Clinical Trial, and Mark Schoenfeld, MD, author of Incidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences. Hosted by Kristen K. Patton, MD. Related Content: Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual CareIncidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences

Duración:00:27:12

Pídele al anfitrión que permita compartir el control de reproducción

Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation

12/14/2022
Interview with Michael J. Reardon, MD, and Daniel O’Hair, MD, authors of Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. Hosted by Robert O. Bonow, MD, MS. Related Content: Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Duración:00:16:59

Pídele al anfitrión que permita compartir el control de reproducción

Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing

11/30/2022
Interview with Mitesh S. Patel, MD, MBA, author of Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial, and Faraz S. Ahmad, MD, MS, author of Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both. Hosted by Sadiya Sana Khan, MD, MS. Related Content: Effect of Nudges to Clinicians, Patients, or Both to Increase Statin PrescribingNudging to Improve Cardiovascular Care—Clinicians, Patients, or Both

Duración:00:16:29

Pídele al anfitrión que permita compartir el control de reproducción

Treatment of Hypertension in 2022

11/8/2022
JAMA Interim Executive Editor Gregory Curfman, MD, interviews Robert M. Carey, MD, University of Virginia, about his review article on treatment of hypertension in the November 8, 2022, issue of JAMA. Their discussion addresses the clinical consequences of hypertension, as well as nonpharmacological and pharmacological approaches to management, including patients with resistant hypertension. Related Content: Treatment of Hypertension More programs like this one are available via the JAMA Clinical Reviews podcast.

Duración:00:27:30

Pídele al anfitrión que permita compartir el control de reproducción

Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control

10/12/2022
Interview with Nicholas M. Pajewski, PhD, author of Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial, and Daniel W. Jones, MD, author of Blood Pressure Control After SPRINT—Back to Reality. Hosted by Gregg C. Fonarow, MD. Related Content: Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure ControlBlood Pressure Control After SPRINT—Back to Reality

Duración:00:17:19

Pídele al anfitrión que permita compartir el control de reproducción

Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features

9/14/2022
Interview with Santhi K. Ganesh, MD, author of Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features, and Sharonne N. Hayes, MD, author of Genetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise. Hosted by Sadiya Sana Khan, MD, MS. Related Content: Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk FeaturesGenetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise

Duración:00:20:04

Pídele al anfitrión que permita compartir el control de reproducción

Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure

8/10/2022
Interview with Tariq Ahmad, MD, MPH, author of Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure: The REVEAL-HF Randomized Clinical Trial, and Rishi K. Wadhera, MD, MPP, MPhil, author of Improving Quality Improvement—From Aspiration Toward Empiricism. Hosted by Gregg C. Fonarow, MD. Related Content: Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart FailureImproving Quality Improvement—From Aspiration Toward Empiricism

Duración:00:17:03